Compare Ganirelix (evidence A) and Gonadorelin (evidence A) on mechanism, clinical status, safety, and dosing.
Ganirelix is a synthetic GnRH antagonist decapeptide (MW ~1570.4 g/mol) FDA-approved for the prevention of premature LH surges during controlled ovarian…
Gonadorelin is a synthetic decapeptide identical to the naturally occurring gonadotropin-releasing hormone (GnRH) produced in the hypothalamus. It stimulates…
Full profiles: Ganirelix, Gonadorelin.